Short-course antidepressant therapy reduces discontinuation syndrome while maintaining treatment efficacy in patients with refractory functional dyspepsia: A randomized controlled trial

BACKGROUND AND OBJECTIVE: Long-course (LC) antidepressants for the treatment of disorders of gut-brain interaction, such as refractory functional dyspepsia (rFD), pose patients at risk of antidepressant discontinuation syndrome (ADS). Short-course (SC) therapy of rapid-acting antidepressant may redu...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Qian-Qian, Cheng, Li, Wu, Bi-Yu, Xu, Ping, Qiu, Hong-Yi, Wang, Bo, Yan, Xiu-Juan, Chen, Sheng-Liang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Psychiatry
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772443/
https://www.ncbi.nlm.nih.gov/pubmed/36569610
http://dx.doi.org/10.3389/fpsyt.2022.1063722

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9772443/
https://www.ncbi.nlm.nih.gov/pubmed/36569610
http://dx.doi.org/10.3389/fpsyt.2022.1063722

Ejemplares similares